Irritable Bowel Syndrome May Be Associated with Elevated Alanine Aminotransferase and Metabolic Syndrome.
10.3349/ymj.2016.57.1.146
- Author:
Seung Hwa LEE
1
;
Kyu Nam KIM
;
Kwang Min KIM
;
Nam Seok JOO
Author Information
1. Department of Family Medicine, Seo-Hae Hospital, Seocheon, Korea.
- Publication Type:Original Article
- Keywords:
Irritable bowel syndrome;
liver enzymes;
metabolic syndrome
- MeSH:
Adult;
Alanine Transaminase/analysis/*metabolism;
Aspartate Aminotransferases/analysis/*metabolism;
Body Mass Index;
Case-Control Studies;
Cross-Sectional Studies;
Female;
Humans;
Irritable Bowel Syndrome/diagnosis/*enzymology/epidemiology;
Liver/metabolism;
Male;
Metabolic Syndrome X/complications/diagnosis/*enzymology/epidemiology;
Middle Aged;
Obesity/epidemiology;
Prevalence;
Retrospective Studies;
Waist Circumference;
gamma-Glutamyltransferase/analysis/*metabolism
- From:Yonsei Medical Journal
2016;57(1):146-152
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Recent studies have revealed close relationships between hepatic injury, metabolic pathways, and gut microbiota. The microorganisms in the intestine also cause irritable bowel syndrome (IBS). The aim of this study was to examine whether IBS was associated with elevated hepatic enzyme [alanine aminotransferase (ALT) and aspartate aminotransferase (AST)], gamma-glutamyl transferase (gamma-GT) levels, and metabolic syndrome (MS). MATERIALS AND METHODS: This was a retrospective, cross-sectional, case-control study. The case and control groups comprised subjects who visited our health promotion center for general check-ups from June 2010 to December 2010. Of the 1127 initially screened subjects, 83 had IBS according to the Rome III criteria. The control group consisted of 260 age- and sex-matched subjects without IBS who visited our health promotion center during the same period. RESULTS: Compared to control subjects, patients with IBS showed significantly higher values of anthropometric parameters (body mass index, waist circumference), liver enzymes, gamma-GT, and lipid levels. The prevalences of elevated ALT (16.9% vs. 7.7%; p=0.015) and gamma-GT (24.1% vs. 11.5%; p=0.037) levels were significantly higher in patients with IBS than in control subjects. A statistically significant difference was observed in the prevalence of MS between controls and IBS patients (12.7% vs. 32.5%; p<0.001). The relationships between elevated ALT levels, MS, and IBS remained statistically significant after controlling for potential confounding factors. CONCLUSION: On the basis of our study results, IBS may be an important condition in certain patients with elevated ALT levels and MS.
